Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,103 | -17,485 | -3,149 | N/A | N/A |
| Depreciation Amortization | 9 | 4 | 5 | N/A | N/A |
| Accounts receivable | -149 | -2 | -11 | N/A | N/A |
| Accounts payable and accrued liabilities | -571 | 1,182 | -192 | N/A | N/A |
| Other Working Capital | -748 | 1,218 | -143 | N/A | N/A |
| Other Operating Activity | 1,321 | 12,559 | 411 | 0 | 0 |
| Operating Cash Flow | $-9,241 | $-2,524 | $-3,079 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -770 | 3 | -32 | N/A | N/A |
| Purchase Of Investment | -2,246 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-9,016 | $3 | $-32 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,840 | N/A | N/A | N/A |
| Common Stock Issued | 41,856 | 120 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -20 | 3,683 | 0 | 0 |
| Financing Cash Flow | $41,856 | $1,940 | $3,683 | $N/A | $N/A |
| Beginning Cash Position | 137 | 718 | 146 | N/A | N/A |
| End Cash Position | 23,736 | 137 | 718 | N/A | N/A |
| Net Cash Flow | $23,599 | $-581 | $572 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,241 | -2,524 | -3,079 | N/A | N/A |
| Capital Expenditure | -770 | -13 | -32 | N/A | N/A |
| Free Cash Flow | -10,011 | -2,537 | -3,111 | 0 | 0 |